Atrion Corp (ATRI): Utang-utang marang kapitalisasi buku

Tandha merek Atrion Corp. (ATRI)

The stable retention of design engineers and quality controllers drives the dynamics of the capital structure risk metric on the GURU.Markets chart, where the value 0.00 serves as the baseline indicator. The business relies on non-cyclical demand for cardiology components, which guarantees macro-stability. Low employee turnover is ensured by a competitive benefits package and a respectful approach to the personnel of Atrion Corporation (ATRI).

ATRI (Atrion Corporation Inc.) riwayat Utang marang nilai buku saka 04.07.2022 nganti 31.08.2024
Produk asli Atrion Corporation Inc.

For Atrion Corporation (ATRI), the debt-to-book capitalization ratio demonstrates the resilience of the ophthalmic equipment manufacturer's capital structure. This indicator compares total liabilities to the net value of assets, revealing the business's degree of reliance on borrowed funds. Reducing leverage minimizes default risk, although it may limit the growth rate of return on investment. For this supplier of critical medical devices, such balance guarantees financial reliability. The stability of this metric confirms a conservative approach to capital management.

Karo sapa Atrion Corporation saingan

ISRG - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku danaher.com DHR|Utang-utang marang kapitalisasi buku BDX (Becton Dickinson)|STE - Utang-utang marang aset resik|WST (West Pharmaceutical Services Inc) - Utang-utang marang kapitalisasi buku|Baxter Healthcare (BAX) - Utang marang nilai buku|MASI (Masimo Corporation) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku STVN|Rasio utang marang kapitalisasi buku Teleflex (TFX)|Rasio utang marang kapitalisasi buku Merit Medical Systems, Inc. MMSI|Utang marang nilai buku Envista Holdings Corp|Rasio utang marang aset resik ICU Medical Inc. ICUI|Utang-utang marang kapitalisasi buku XRAY (DENTSPLY SIRONA Inc.)|LMAT: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku AtriCure|STAA (STAAR Surgical Co.) - Rasio utang marang nilai buku|NAGE: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik ZimVie Corp (ZIMV)|Utang marang nilai buku AngioDynamics, Inc.|Utang marang modal buku CERS (cerus.com)|Rasio utang marang kapitalisasi buku Teknova|MGRM - Rasio utang marang aset resik|Sharps Tech - Utang marang nilai buku|INFU: Utang-utang marang kapitalisasi buku|UTMD (Utah Medical Products) - Rasio utang marang kapitalisasi buku|KORU Medical (KRMD) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku NYXH (Nyxoah)|Utang-utang marang nilai buku MBOT|Rasio utang marang kapitalisasi buku Pro-Dex Corp PDEX|Rasio utang marang nilai buku Zentek Corp ZTEK|Utang marang nilai buku Elutia Inc. (ELUT)|milestonescientific.com - Utang marang modal buku|Rasio utang marang kapitalisasi buku NXGL (NEXGEL)|RVP - Utang-utang marang aset resik|HBIO: Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku Femasys Corporation|Meihua Medical Technologies (MHUA) - Utang marang nilai buku|Utang marang modal buku POAI|Callan JMB Inc (CJMB) - Rasio utang marang kapitalisasi buku|Rasio utang marang aset resik NeuroMetrix Inc (NURO)